亚妮儿2014-03-28 11:50
$亿胜生物科技(01061)$ 转:在我看来,这是一个值得长期持有的好股票,而且回报将会非常的好。理由如下,欢迎拍砖,让我好好醒醒:
1.公司主要的产品BFGF是生物制药,有着修复功能,意味着和以往化学药物减轻病症而无法治愈的效果不同,它能够治愈,而且能治愈很多之前无法治愈的病症,如心血管...查看全文
牛得草2014-03-22 07:18
$赛托瑞医疗(CYTX)$ Okyanos已经完成1400万美元的融资,今年夏天开业,他在巴哈马岛是以cytori细胞疗法治疗慢性心脏病,通过离岸医疗的方式绕过FDA吸引美国患者来巴哈马治疗,预计每年1000人的治疗规模,cytori的Celution®设备10万美元一台,试剂2000-10000美元一支,2000美元的是用于整形的试剂...查看全文
用户55807238042014-03-18 17:01
报告作者:Medi-Khan
相关股票:$赛托瑞医疗(CYTX)$
Medi-Khan是一个韩国人在LA开的公司。这是2008年该公司的一个报告。
网页链接查看全文
$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接
$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001564590-19-025075 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-11 AccNo: 0001564590-19-024844 Size: 64 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001564590-19-024571 Size: 40 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...